nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolcapone—COMT—breast cancer	0.505	1	CbGaD
Tolcapone—CYP2C9—Anastrozole—breast cancer	0.0676	0.332	CbGbCtD
Tolcapone—CYP2C9—Idarubicin—breast cancer	0.0513	0.251	CbGbCtD
Tolcapone—CYP2C9—Capecitabine—breast cancer	0.0281	0.138	CbGbCtD
Tolcapone—CYP2C9—Tamoxifen—breast cancer	0.0226	0.111	CbGbCtD
Tolcapone—CYP2C9—Paclitaxel—breast cancer	0.0176	0.0863	CbGbCtD
Tolcapone—CYP2C9—Fluorouracil—breast cancer	0.0167	0.0817	CbGbCtD
Tolcapone—Entacapone—COMT—breast cancer	0.0023	0.422	CrCbGaD
Tolcapone—Niclosamide—STAT3—breast cancer	0.00207	0.378	CrCbGaD
Tolcapone—COMT—nipple—breast cancer	0.00104	0.131	CbGeAlD
Tolcapone—COMT—skin of body—breast cancer	0.000669	0.0838	CbGeAlD
Tolcapone—CYP2C9—mammary gland—breast cancer	0.000664	0.0832	CbGeAlD
Tolcapone—COMT—endometrium—breast cancer	0.000631	0.079	CbGeAlD
Tolcapone—Tolmetin—CXCL8—breast cancer	0.000607	0.111	CrCbGaD
Tolcapone—COMT—uterus—breast cancer	0.000581	0.0728	CbGeAlD
Tolcapone—COMT—pituitary gland—breast cancer	0.000571	0.0715	CbGeAlD
Tolcapone—COMT—adipose tissue—breast cancer	0.000569	0.0712	CbGeAlD
Tolcapone—COMT—female reproductive system—breast cancer	0.000523	0.0654	CbGeAlD
Tolcapone—COMT—adrenal gland—breast cancer	0.00051	0.0639	CbGeAlD
Tolcapone—COMT—bone marrow—breast cancer	0.000493	0.0618	CbGeAlD
Tolcapone—COMT—female gonad—breast cancer	0.000476	0.0596	CbGeAlD
Tolcapone—COMT—endocrine gland—breast cancer	0.000442	0.0554	CbGeAlD
Tolcapone—Tolmetin—PTGS1—breast cancer	0.00031	0.0566	CrCbGaD
Tolcapone—COMT—lymph node—breast cancer	0.000306	0.0383	CbGeAlD
Tolcapone—CYP2C9—female reproductive system—breast cancer	0.000275	0.0344	CbGeAlD
Tolcapone—CYP2C9—endocrine gland—breast cancer	0.000232	0.0291	CbGeAlD
Tolcapone—Tolmetin—PTGS2—breast cancer	0.000177	0.0324	CrCbGaD
Tolcapone—CYP2C9—Phase 1 - Functionalization of compounds—NCOA1—breast cancer	7.99e-05	0.00155	CbGpPWpGaD
Tolcapone—CYP2C9—Phase 1 - Functionalization of compounds—CYP19A1—breast cancer	7.88e-05	0.00153	CbGpPWpGaD
Tolcapone—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—breast cancer	7.83e-05	0.00152	CbGpPWpGaD
Tolcapone—CYP2C9—Biological oxidations—GSTA4—breast cancer	7.75e-05	0.0015	CbGpPWpGaD
Tolcapone—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—breast cancer	7.73e-05	0.0015	CbGpPWpGaD
Tolcapone—COMT—Metabolism—SLC2A5—breast cancer	7.71e-05	0.00149	CbGpPWpGaD
Tolcapone—COMT—Metabolism—SLCO1B1—breast cancer	7.71e-05	0.00149	CbGpPWpGaD
Tolcapone—CYP2C9—Metapathway biotransformation—GSTA4—breast cancer	7.64e-05	0.00148	CbGpPWpGaD
Tolcapone—CYP2C9—Biological oxidations—GSTA2—breast cancer	7.55e-05	0.00146	CbGpPWpGaD
Tolcapone—CYP2C9—Biological oxidations—SULT1A1—breast cancer	7.46e-05	0.00144	CbGpPWpGaD
Tolcapone—CYP2C9—Metapathway biotransformation—GPX2—breast cancer	7.45e-05	0.00144	CbGpPWpGaD
Tolcapone—COMT—Metabolism—APRT—breast cancer	7.45e-05	0.00144	CbGpPWpGaD
Tolcapone—CYP2C9—Metapathway biotransformation—SULT1A1—breast cancer	7.36e-05	0.00142	CbGpPWpGaD
Tolcapone—CYP2C9—Metapathway biotransformation—GPX4—breast cancer	7.36e-05	0.00142	CbGpPWpGaD
Tolcapone—CYP2C9—Biological oxidations—GSTA1—breast cancer	7.29e-05	0.00141	CbGpPWpGaD
Tolcapone—CYP2C9—Biological oxidations—NAT2—breast cancer	7.2e-05	0.0014	CbGpPWpGaD
Tolcapone—COMT—Transmission across Chemical Synapses—MDM2—breast cancer	7.18e-05	0.00139	CbGpPWpGaD
Tolcapone—COMT—Transmission across Chemical Synapses—RAF1—breast cancer	7.16e-05	0.00139	CbGpPWpGaD
Tolcapone—CYP2C9—Metapathway biotransformation—NAT2—breast cancer	7.11e-05	0.00138	CbGpPWpGaD
Tolcapone—COMT—Metabolism—ESRRA—breast cancer	7e-05	0.00136	CbGpPWpGaD
Tolcapone—COMT—Metabolism—ANGPTL4—breast cancer	7e-05	0.00136	CbGpPWpGaD
Tolcapone—COMT—Metabolism—GPI—breast cancer	6.64e-05	0.00129	CbGpPWpGaD
Tolcapone—COMT—Metabolism—HADHB—breast cancer	6.64e-05	0.00129	CbGpPWpGaD
Tolcapone—COMT—Neuronal System—BRAF—breast cancer	6.57e-05	0.00127	CbGpPWpGaD
Tolcapone—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—breast cancer	6.35e-05	0.00123	CbGpPWpGaD
Tolcapone—COMT—Metabolism—ALDH1A1—breast cancer	6.33e-05	0.00123	CbGpPWpGaD
Tolcapone—COMT—Metabolism—ALDH7A1—breast cancer	6.33e-05	0.00123	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—SYNJ2—breast cancer	6.09e-05	0.00118	CbGpPWpGaD
Tolcapone—COMT—Metabolism—PHGDH—breast cancer	6.07e-05	0.00118	CbGpPWpGaD
Tolcapone—COMT—Metabolism—UMPS—breast cancer	6.07e-05	0.00118	CbGpPWpGaD
Tolcapone—COMT—Metabolism—NME1—breast cancer	6.07e-05	0.00118	CbGpPWpGaD
Tolcapone—COMT—Metabolism—ADSL—breast cancer	6.07e-05	0.00118	CbGpPWpGaD
Tolcapone—COMT—Metabolism—FHL2—breast cancer	6.07e-05	0.00118	CbGpPWpGaD
Tolcapone—COMT—Metabolism—BRIP1—breast cancer	5.95e-05	0.00115	CbGpPWpGaD
Tolcapone—COMT—Metabolism—HPSE—breast cancer	5.95e-05	0.00115	CbGpPWpGaD
Tolcapone—COMT—Metabolism—LDHB—breast cancer	5.95e-05	0.00115	CbGpPWpGaD
Tolcapone—CYP2C9—Biological oxidations—MTR—breast cancer	5.87e-05	0.00114	CbGpPWpGaD
Tolcapone—CYP2C9—Biological oxidations—HPGDS—breast cancer	5.76e-05	0.00112	CbGpPWpGaD
Tolcapone—COMT—Metabolism—ABCC1—breast cancer	5.64e-05	0.00109	CbGpPWpGaD
Tolcapone—COMT—Metabolism—GSTA3—breast cancer	5.64e-05	0.00109	CbGpPWpGaD
Tolcapone—COMT—Metabolism—HMMR—breast cancer	5.64e-05	0.00109	CbGpPWpGaD
Tolcapone—CYP2C9—Biological oxidations—GSTT1—breast cancer	5.59e-05	0.00108	CbGpPWpGaD
Tolcapone—COMT—Neuronal System—MDM2—breast cancer	5.5e-05	0.00107	CbGpPWpGaD
Tolcapone—COMT—Neuronal System—RAF1—breast cancer	5.48e-05	0.00106	CbGpPWpGaD
Tolcapone—COMT—Metabolism—PPARGC1B—breast cancer	5.47e-05	0.00106	CbGpPWpGaD
Tolcapone—CYP2C9—Arachidonic acid metabolism—PTGS2—breast cancer	5.39e-05	0.00104	CbGpPWpGaD
Tolcapone—CYP2C9—Biological oxidations—CYP17A1—breast cancer	5.29e-05	0.00102	CbGpPWpGaD
Tolcapone—CYP2C9—Biological oxidations—PTGS1—breast cancer	5.23e-05	0.00101	CbGpPWpGaD
Tolcapone—CYP2C9—Metapathway biotransformation—CYP17A1—breast cancer	5.22e-05	0.00101	CbGpPWpGaD
Tolcapone—COMT—Metabolism—CA9—breast cancer	5.16e-05	0.001	CbGpPWpGaD
Tolcapone—COMT—Metabolism—GSTA4—breast cancer	5.16e-05	0.001	CbGpPWpGaD
Tolcapone—CYP2C9—Biological oxidations—CYP2D6—breast cancer	5.13e-05	0.000994	CbGpPWpGaD
Tolcapone—CYP2C9—Metapathway biotransformation—CYP2D6—breast cancer	5.06e-05	0.000981	CbGpPWpGaD
Tolcapone—CYP2C9—Biological oxidations—NCOA2—breast cancer	5.04e-05	0.000976	CbGpPWpGaD
Tolcapone—COMT—Metabolism—GPX2—breast cancer	5.03e-05	0.000974	CbGpPWpGaD
Tolcapone—COMT—Metabolism—GSTA2—breast cancer	5.03e-05	0.000974	CbGpPWpGaD
Tolcapone—COMT—Metabolism—GPX4—breast cancer	4.97e-05	0.000962	CbGpPWpGaD
Tolcapone—COMT—Metabolism—SULT1A1—breast cancer	4.97e-05	0.000962	CbGpPWpGaD
Tolcapone—COMT—Metabolism—IDH1—breast cancer	4.85e-05	0.00094	CbGpPWpGaD
Tolcapone—COMT—Metabolism—GSTA1—breast cancer	4.85e-05	0.00094	CbGpPWpGaD
Tolcapone—COMT—Metabolism—NAT2—breast cancer	4.8e-05	0.000929	CbGpPWpGaD
Tolcapone—CYP2C9—Biological oxidations—CYP3A4—breast cancer	4.53e-05	0.000877	CbGpPWpGaD
Tolcapone—CYP2C9—Metapathway biotransformation—CYP3A4—breast cancer	4.47e-05	0.000865	CbGpPWpGaD
Tolcapone—CYP2C9—Biological oxidations—CYP1B1—breast cancer	4.45e-05	0.000862	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—SLCO1B1—breast cancer	4.45e-05	0.000861	CbGpPWpGaD
Tolcapone—CYP2C9—Metapathway biotransformation—CYP1B1—breast cancer	4.39e-05	0.00085	CbGpPWpGaD
Tolcapone—CYP2C9—Biological oxidations—NCOA1—breast cancer	4.25e-05	0.000822	CbGpPWpGaD
Tolcapone—COMT—Metabolism—DPYD—breast cancer	4.21e-05	0.000815	CbGpPWpGaD
Tolcapone—COMT—Metabolism—MED12—breast cancer	4.21e-05	0.000815	CbGpPWpGaD
Tolcapone—CYP2C9—Biological oxidations—CYP19A1—breast cancer	4.18e-05	0.00081	CbGpPWpGaD
Tolcapone—COMT—Metabolism—ALDOA—breast cancer	4.14e-05	0.000802	CbGpPWpGaD
Tolcapone—CYP2C9—Metapathway biotransformation—CYP19A1—breast cancer	4.13e-05	0.000799	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—ESRRA—breast cancer	4.04e-05	0.000782	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—ANGPTL4—breast cancer	4.04e-05	0.000782	CbGpPWpGaD
Tolcapone—COMT—Metabolism—NCOA3—breast cancer	4.02e-05	0.000779	CbGpPWpGaD
Tolcapone—COMT—Metabolism—SLC2A2—breast cancer	3.99e-05	0.000773	CbGpPWpGaD
Tolcapone—COMT—Transmission across Chemical Synapses—HRAS—breast cancer	3.94e-05	0.000763	CbGpPWpGaD
Tolcapone—COMT—Metabolism—ABCG2—breast cancer	3.91e-05	0.000758	CbGpPWpGaD
Tolcapone—COMT—Metabolism—CPT1A—breast cancer	3.91e-05	0.000758	CbGpPWpGaD
Tolcapone—COMT—Metabolism—MTR—breast cancer	3.91e-05	0.000758	CbGpPWpGaD
Tolcapone—CYP2C9—Biological oxidations—COMT—breast cancer	3.89e-05	0.000753	CbGpPWpGaD
Tolcapone—CYP2C9—Biological oxidations—GSTP1—breast cancer	3.87e-05	0.00075	CbGpPWpGaD
Tolcapone—CYP2C9—Metapathway biotransformation—COMT—breast cancer	3.84e-05	0.000743	CbGpPWpGaD
Tolcapone—COMT—Metabolism—HPGDS—breast cancer	3.84e-05	0.000743	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—HADHB—breast cancer	3.83e-05	0.000741	CbGpPWpGaD
Tolcapone—CYP2C9—Metapathway biotransformation—GSTP1—breast cancer	3.82e-05	0.00074	CbGpPWpGaD
Tolcapone—COMT—Metabolism—HBA1—breast cancer	3.81e-05	0.000738	CbGpPWpGaD
Tolcapone—COMT—Metabolism—GSTT1—breast cancer	3.72e-05	0.000721	CbGpPWpGaD
Tolcapone—COMT—Metabolism—ACHE—breast cancer	3.72e-05	0.000721	CbGpPWpGaD
Tolcapone—CYP2C9—Biological oxidations—GSTM1—breast cancer	3.56e-05	0.000689	CbGpPWpGaD
Tolcapone—COMT—Metabolism—CYP17A1—breast cancer	3.52e-05	0.000682	CbGpPWpGaD
Tolcapone—CYP2C9—Metapathway biotransformation—GSTM1—breast cancer	3.51e-05	0.00068	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—FHL2—breast cancer	3.5e-05	0.000678	CbGpPWpGaD
Tolcapone—COMT—Metabolism—ENO1—breast cancer	3.49e-05	0.000675	CbGpPWpGaD
Tolcapone—COMT—Metabolism—PTGS1—breast cancer	3.49e-05	0.000675	CbGpPWpGaD
Tolcapone—COMT—Metabolism—CYP2D6—breast cancer	3.42e-05	0.000662	CbGpPWpGaD
Tolcapone—CYP2C9—Biological oxidations—CYP1A1—breast cancer	3.37e-05	0.000653	CbGpPWpGaD
Tolcapone—COMT—Metabolism—NCOA2—breast cancer	3.36e-05	0.00065	CbGpPWpGaD
Tolcapone—CYP2C9—Metapathway biotransformation—CYP1A1—breast cancer	3.33e-05	0.000644	CbGpPWpGaD
Tolcapone—COMT—Metabolism—FASN—breast cancer	3.26e-05	0.00063	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—ABCC1—breast cancer	3.25e-05	0.00063	CbGpPWpGaD
Tolcapone—COMT—Metabolism—BCHE—breast cancer	3.24e-05	0.000628	CbGpPWpGaD
Tolcapone—COMT—Metabolism—SLC5A5—breast cancer	3.2e-05	0.00062	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1B—breast cancer	3.15e-05	0.00061	CbGpPWpGaD
Tolcapone—COMT—Metabolism—NQO1—breast cancer	3.09e-05	0.000599	CbGpPWpGaD
Tolcapone—COMT—Metabolism—SLC2A1—breast cancer	3.09e-05	0.000599	CbGpPWpGaD
Tolcapone—Rash—Gemcitabine—breast cancer	3.03e-05	0.000134	CcSEcCtD
Tolcapone—Dermatitis—Gemcitabine—breast cancer	3.03e-05	0.000134	CcSEcCtD
Tolcapone—Tinnitus—Epirubicin—breast cancer	3.02e-05	0.000134	CcSEcCtD
Tolcapone—COMT—Neuronal System—HRAS—breast cancer	3.02e-05	0.000585	CbGpPWpGaD
Tolcapone—COMT—Metabolism—CYP3A4—breast cancer	3.02e-05	0.000584	CbGpPWpGaD
Tolcapone—Haemoglobin—Doxorubicin—breast cancer	3.01e-05	0.000133	CcSEcCtD
Tolcapone—Headache—Gemcitabine—breast cancer	3.01e-05	0.000133	CcSEcCtD
Tolcapone—Musculoskeletal discomfort—Capecitabine—breast cancer	3.01e-05	0.000133	CcSEcCtD
Tolcapone—Vomiting—Fluorouracil—breast cancer	3.01e-05	0.000133	CcSEcCtD
Tolcapone—Rhinitis—Doxorubicin—breast cancer	3.01e-05	0.000133	CcSEcCtD
Tolcapone—Dyspepsia—Docetaxel—breast cancer	3e-05	0.000133	CcSEcCtD
Tolcapone—Haemorrhage—Doxorubicin—breast cancer	3e-05	0.000133	CcSEcCtD
Tolcapone—Hypoaesthesia—Doxorubicin—breast cancer	2.98e-05	0.000132	CcSEcCtD
Tolcapone—Rash—Fluorouracil—breast cancer	2.98e-05	0.000132	CcSEcCtD
Tolcapone—Dermatitis—Fluorouracil—breast cancer	2.98e-05	0.000132	CcSEcCtD
Tolcapone—Pharyngitis—Doxorubicin—breast cancer	2.98e-05	0.000132	CcSEcCtD
Tolcapone—Paraesthesia—Capecitabine—breast cancer	2.97e-05	0.000131	CcSEcCtD
Tolcapone—Decreased appetite—Docetaxel—breast cancer	2.97e-05	0.000131	CcSEcCtD
Tolcapone—Hypersensitivity—Paclitaxel—breast cancer	2.97e-05	0.000131	CcSEcCtD
Tolcapone—COMT—Metabolism—CYP1B1—breast cancer	2.96e-05	0.000574	CbGpPWpGaD
Tolcapone—Headache—Fluorouracil—breast cancer	2.96e-05	0.000131	CcSEcCtD
Tolcapone—Urinary tract disorder—Doxorubicin—breast cancer	2.96e-05	0.000131	CcSEcCtD
Tolcapone—Oedema peripheral—Doxorubicin—breast cancer	2.95e-05	0.000131	CcSEcCtD
Tolcapone—Dysgeusia—Methotrexate—breast cancer	2.95e-05	0.000131	CcSEcCtD
Tolcapone—Gastrointestinal disorder—Docetaxel—breast cancer	2.95e-05	0.00013	CcSEcCtD
Tolcapone—Dyspnoea—Capecitabine—breast cancer	2.95e-05	0.00013	CcSEcCtD
Tolcapone—Fatigue—Docetaxel—breast cancer	2.94e-05	0.00013	CcSEcCtD
Tolcapone—Angiopathy—Epirubicin—breast cancer	2.94e-05	0.00013	CcSEcCtD
Tolcapone—Urethral disorder—Doxorubicin—breast cancer	2.94e-05	0.00013	CcSEcCtD
Tolcapone—Nausea—Mitoxantrone—breast cancer	2.93e-05	0.00013	CcSEcCtD
Tolcapone—Nausea—Irinotecan—breast cancer	2.93e-05	0.00013	CcSEcCtD
Tolcapone—Mediastinal disorder—Epirubicin—breast cancer	2.92e-05	0.000129	CcSEcCtD
Tolcapone—Pain—Docetaxel—breast cancer	2.92e-05	0.000129	CcSEcCtD
Tolcapone—Constipation—Docetaxel—breast cancer	2.92e-05	0.000129	CcSEcCtD
Tolcapone—Dyspepsia—Capecitabine—breast cancer	2.91e-05	0.000129	CcSEcCtD
Tolcapone—COMT—Metabolism—HSP90AA1—breast cancer	2.91e-05	0.000563	CbGpPWpGaD
Tolcapone—Chills—Epirubicin—breast cancer	2.91e-05	0.000129	CcSEcCtD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—GPX2—breast cancer	2.9e-05	0.000562	CbGpPWpGaD
Tolcapone—Arrhythmia—Epirubicin—breast cancer	2.89e-05	0.000128	CcSEcCtD
Tolcapone—Asthenia—Paclitaxel—breast cancer	2.89e-05	0.000128	CcSEcCtD
Tolcapone—Decreased appetite—Capecitabine—breast cancer	2.87e-05	0.000127	CcSEcCtD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—GPX4—breast cancer	2.86e-05	0.000555	CbGpPWpGaD
Tolcapone—Alopecia—Epirubicin—breast cancer	2.86e-05	0.000127	CcSEcCtD
Tolcapone—Nausea—Gemcitabine—breast cancer	2.86e-05	0.000126	CcSEcCtD
Tolcapone—Gastrointestinal disorder—Capecitabine—breast cancer	2.85e-05	0.000126	CcSEcCtD
Tolcapone—Fatigue—Capecitabine—breast cancer	2.85e-05	0.000126	CcSEcCtD
Tolcapone—Pruritus—Paclitaxel—breast cancer	2.85e-05	0.000126	CcSEcCtD
Tolcapone—Vision blurred—Methotrexate—breast cancer	2.84e-05	0.000126	CcSEcCtD
Tolcapone—Mental disorder—Epirubicin—breast cancer	2.84e-05	0.000126	CcSEcCtD
Tolcapone—Erythema multiforme—Doxorubicin—breast cancer	2.83e-05	0.000126	CcSEcCtD
Tolcapone—COMT—Metabolism—NCOA1—breast cancer	2.83e-05	0.000548	CbGpPWpGaD
Tolcapone—Constipation—Capecitabine—breast cancer	2.83e-05	0.000125	CcSEcCtD
Tolcapone—Pain—Capecitabine—breast cancer	2.83e-05	0.000125	CcSEcCtD
Tolcapone—Feeling abnormal—Docetaxel—breast cancer	2.81e-05	0.000125	CcSEcCtD
Tolcapone—Nausea—Fluorouracil—breast cancer	2.81e-05	0.000124	CcSEcCtD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—breast cancer	2.8e-05	0.000542	CbGpPWpGaD
Tolcapone—Ill-defined disorder—Methotrexate—breast cancer	2.8e-05	0.000124	CcSEcCtD
Tolcapone—Tinnitus—Doxorubicin—breast cancer	2.79e-05	0.000124	CcSEcCtD
Tolcapone—Gastrointestinal pain—Docetaxel—breast cancer	2.79e-05	0.000124	CcSEcCtD
Tolcapone—COMT—Metabolism—STK11—breast cancer	2.79e-05	0.00054	CbGpPWpGaD
Tolcapone—COMT—Metabolism—CYP19A1—breast cancer	2.79e-05	0.00054	CbGpPWpGaD
Tolcapone—Anaemia—Methotrexate—breast cancer	2.79e-05	0.000123	CcSEcCtD
Tolcapone—Flatulence—Epirubicin—breast cancer	2.78e-05	0.000123	CcSEcCtD
Tolcapone—Tension—Epirubicin—breast cancer	2.77e-05	0.000123	CcSEcCtD
Tolcapone—Dysgeusia—Epirubicin—breast cancer	2.76e-05	0.000122	CcSEcCtD
Tolcapone—Diarrhoea—Paclitaxel—breast cancer	2.75e-05	0.000122	CcSEcCtD
Tolcapone—Nervousness—Epirubicin—breast cancer	2.74e-05	0.000121	CcSEcCtD
Tolcapone—Feeling abnormal—Capecitabine—breast cancer	2.72e-05	0.000121	CcSEcCtD
Tolcapone—Angiopathy—Doxorubicin—breast cancer	2.72e-05	0.00012	CcSEcCtD
Tolcapone—Malaise—Methotrexate—breast cancer	2.72e-05	0.00012	CcSEcCtD
Tolcapone—CYP2C9—Metabolism—SYNJ2—breast cancer	2.71e-05	0.000526	CbGpPWpGaD
Tolcapone—Muscle spasms—Epirubicin—breast cancer	2.71e-05	0.00012	CcSEcCtD
Tolcapone—Vertigo—Methotrexate—breast cancer	2.71e-05	0.00012	CcSEcCtD
Tolcapone—Gastrointestinal pain—Capecitabine—breast cancer	2.7e-05	0.00012	CcSEcCtD
Tolcapone—Mediastinal disorder—Doxorubicin—breast cancer	2.7e-05	0.00012	CcSEcCtD
Tolcapone—Body temperature increased—Docetaxel—breast cancer	2.7e-05	0.000119	CcSEcCtD
Tolcapone—Abdominal pain—Docetaxel—breast cancer	2.7e-05	0.000119	CcSEcCtD
Tolcapone—Chills—Doxorubicin—breast cancer	2.69e-05	0.000119	CcSEcCtD
Tolcapone—Arrhythmia—Doxorubicin—breast cancer	2.68e-05	0.000119	CcSEcCtD
Tolcapone—Dizziness—Paclitaxel—breast cancer	2.66e-05	0.000118	CcSEcCtD
Tolcapone—Vision blurred—Epirubicin—breast cancer	2.66e-05	0.000118	CcSEcCtD
Tolcapone—Alopecia—Doxorubicin—breast cancer	2.65e-05	0.000117	CcSEcCtD
Tolcapone—Cough—Methotrexate—breast cancer	2.63e-05	0.000116	CcSEcCtD
Tolcapone—Mental disorder—Doxorubicin—breast cancer	2.63e-05	0.000116	CcSEcCtD
Tolcapone—Urticaria—Capecitabine—breast cancer	2.62e-05	0.000116	CcSEcCtD
Tolcapone—Ill-defined disorder—Epirubicin—breast cancer	2.62e-05	0.000116	CcSEcCtD
Tolcapone—Body temperature increased—Capecitabine—breast cancer	2.61e-05	0.000116	CcSEcCtD
Tolcapone—Abdominal pain—Capecitabine—breast cancer	2.61e-05	0.000116	CcSEcCtD
Tolcapone—Anaemia—Epirubicin—breast cancer	2.61e-05	0.000115	CcSEcCtD
Tolcapone—Agitation—Epirubicin—breast cancer	2.59e-05	0.000115	CcSEcCtD
Tolcapone—COMT—Metabolism—GSTP1—breast cancer	2.58e-05	0.0005	CbGpPWpGaD
Tolcapone—Flatulence—Doxorubicin—breast cancer	2.57e-05	0.000114	CcSEcCtD
Tolcapone—Myalgia—Methotrexate—breast cancer	2.57e-05	0.000114	CcSEcCtD
Tolcapone—Arthralgia—Methotrexate—breast cancer	2.57e-05	0.000114	CcSEcCtD
Tolcapone—Chest pain—Methotrexate—breast cancer	2.57e-05	0.000114	CcSEcCtD
Tolcapone—Tension—Doxorubicin—breast cancer	2.56e-05	0.000113	CcSEcCtD
Tolcapone—Vomiting—Paclitaxel—breast cancer	2.56e-05	0.000113	CcSEcCtD
Tolcapone—Dysgeusia—Doxorubicin—breast cancer	2.56e-05	0.000113	CcSEcCtD
Tolcapone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	2.55e-05	0.000113	CcSEcCtD
Tolcapone—COMT—Metabolism—HMOX1—breast cancer	2.54e-05	0.000493	CbGpPWpGaD
Tolcapone—Malaise—Epirubicin—breast cancer	2.54e-05	0.000113	CcSEcCtD
Tolcapone—Rash—Paclitaxel—breast cancer	2.54e-05	0.000112	CcSEcCtD
Tolcapone—COMT—Metabolism—ITPR1—breast cancer	2.54e-05	0.000492	CbGpPWpGaD
Tolcapone—Dermatitis—Paclitaxel—breast cancer	2.54e-05	0.000112	CcSEcCtD
Tolcapone—Discomfort—Methotrexate—breast cancer	2.53e-05	0.000112	CcSEcCtD
Tolcapone—Nervousness—Doxorubicin—breast cancer	2.53e-05	0.000112	CcSEcCtD
Tolcapone—Vertigo—Epirubicin—breast cancer	2.53e-05	0.000112	CcSEcCtD
Tolcapone—Syncope—Epirubicin—breast cancer	2.53e-05	0.000112	CcSEcCtD
Tolcapone—CYP2C9—Metabolism—NDUFS3—breast cancer	2.52e-05	0.000489	CbGpPWpGaD
Tolcapone—Headache—Paclitaxel—breast cancer	2.52e-05	0.000112	CcSEcCtD
Tolcapone—Hypersensitivity—Docetaxel—breast cancer	2.51e-05	0.000111	CcSEcCtD
Tolcapone—Muscle spasms—Doxorubicin—breast cancer	2.51e-05	0.000111	CcSEcCtD
Tolcapone—Palpitations—Epirubicin—breast cancer	2.49e-05	0.00011	CcSEcCtD
Tolcapone—Confusional state—Methotrexate—breast cancer	2.48e-05	0.00011	CcSEcCtD
Tolcapone—Loss of consciousness—Epirubicin—breast cancer	2.48e-05	0.00011	CcSEcCtD
Tolcapone—Cough—Epirubicin—breast cancer	2.46e-05	0.000109	CcSEcCtD
Tolcapone—Vision blurred—Doxorubicin—breast cancer	2.46e-05	0.000109	CcSEcCtD
Tolcapone—Asthenia—Docetaxel—breast cancer	2.45e-05	0.000108	CcSEcCtD
Tolcapone—Infection—Methotrexate—breast cancer	2.44e-05	0.000108	CcSEcCtD
Tolcapone—COMT—Metabolism—ABCB1—breast cancer	2.44e-05	0.000473	CbGpPWpGaD
Tolcapone—Hypertension—Epirubicin—breast cancer	2.43e-05	0.000108	CcSEcCtD
Tolcapone—Hypersensitivity—Capecitabine—breast cancer	2.43e-05	0.000108	CcSEcCtD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—MED12—breast cancer	2.43e-05	0.00047	CbGpPWpGaD
Tolcapone—Ill-defined disorder—Doxorubicin—breast cancer	2.42e-05	0.000107	CcSEcCtD
Tolcapone—Pruritus—Docetaxel—breast cancer	2.41e-05	0.000107	CcSEcCtD
Tolcapone—Nervous system disorder—Methotrexate—breast cancer	2.41e-05	0.000107	CcSEcCtD
Tolcapone—Anaemia—Doxorubicin—breast cancer	2.41e-05	0.000107	CcSEcCtD
Tolcapone—Thrombocytopenia—Methotrexate—breast cancer	2.41e-05	0.000107	CcSEcCtD
Tolcapone—Myalgia—Epirubicin—breast cancer	2.4e-05	0.000106	CcSEcCtD
Tolcapone—Chest pain—Epirubicin—breast cancer	2.4e-05	0.000106	CcSEcCtD
Tolcapone—Arthralgia—Epirubicin—breast cancer	2.4e-05	0.000106	CcSEcCtD
Tolcapone—Agitation—Doxorubicin—breast cancer	2.4e-05	0.000106	CcSEcCtD
Tolcapone—COMT—Metabolism—TYMS—breast cancer	2.4e-05	0.000464	CbGpPWpGaD
Tolcapone—Anxiety—Epirubicin—breast cancer	2.39e-05	0.000106	CcSEcCtD
Tolcapone—Nausea—Paclitaxel—breast cancer	2.39e-05	0.000106	CcSEcCtD
Tolcapone—Skin disorder—Methotrexate—breast cancer	2.39e-05	0.000106	CcSEcCtD
Tolcapone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	2.38e-05	0.000106	CcSEcCtD
Tolcapone—Hyperhidrosis—Methotrexate—breast cancer	2.38e-05	0.000105	CcSEcCtD
Tolcapone—Discomfort—Epirubicin—breast cancer	2.37e-05	0.000105	CcSEcCtD
Tolcapone—CYP2C9—Metabolism—CHST9—breast cancer	2.37e-05	0.000459	CbGpPWpGaD
Tolcapone—Asthenia—Capecitabine—breast cancer	2.37e-05	0.000105	CcSEcCtD
Tolcapone—COMT—Metabolism—NCOR1—breast cancer	2.37e-05	0.000459	CbGpPWpGaD
Tolcapone—COMT—Metabolism—PLA2G4A—breast cancer	2.37e-05	0.000459	CbGpPWpGaD
Tolcapone—COMT—Metabolism—GSTM1—breast cancer	2.37e-05	0.000459	CbGpPWpGaD
Tolcapone—Malaise—Doxorubicin—breast cancer	2.35e-05	0.000104	CcSEcCtD
Tolcapone—Dry mouth—Epirubicin—breast cancer	2.35e-05	0.000104	CcSEcCtD
Tolcapone—Vertigo—Doxorubicin—breast cancer	2.34e-05	0.000104	CcSEcCtD
Tolcapone—Anorexia—Methotrexate—breast cancer	2.34e-05	0.000104	CcSEcCtD
Tolcapone—Syncope—Doxorubicin—breast cancer	2.34e-05	0.000104	CcSEcCtD
Tolcapone—Pruritus—Capecitabine—breast cancer	2.34e-05	0.000104	CcSEcCtD
Tolcapone—Diarrhoea—Docetaxel—breast cancer	2.33e-05	0.000103	CcSEcCtD
Tolcapone—Confusional state—Epirubicin—breast cancer	2.32e-05	0.000103	CcSEcCtD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—NCOA3—breast cancer	2.32e-05	0.000449	CbGpPWpGaD
Tolcapone—Palpitations—Doxorubicin—breast cancer	2.31e-05	0.000102	CcSEcCtD
Tolcapone—Oedema—Epirubicin—breast cancer	2.3e-05	0.000102	CcSEcCtD
Tolcapone—Hypotension—Methotrexate—breast cancer	2.3e-05	0.000102	CcSEcCtD
Tolcapone—Loss of consciousness—Doxorubicin—breast cancer	2.29e-05	0.000102	CcSEcCtD
Tolcapone—Infection—Epirubicin—breast cancer	2.29e-05	0.000101	CcSEcCtD
Tolcapone—Cough—Doxorubicin—breast cancer	2.28e-05	0.000101	CcSEcCtD
Tolcapone—COMT—Metabolism—GPX1—breast cancer	2.27e-05	0.00044	CbGpPWpGaD
Tolcapone—Shock—Epirubicin—breast cancer	2.26e-05	0.0001	CcSEcCtD
Tolcapone—Diarrhoea—Capecitabine—breast cancer	2.26e-05	0.0001	CcSEcCtD
Tolcapone—Nervous system disorder—Epirubicin—breast cancer	2.26e-05	0.0001	CcSEcCtD
Tolcapone—Dizziness—Docetaxel—breast cancer	2.26e-05	9.99e-05	CcSEcCtD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—CPT1A—breast cancer	2.26e-05	0.000437	CbGpPWpGaD
Tolcapone—Thrombocytopenia—Epirubicin—breast cancer	2.25e-05	9.98e-05	CcSEcCtD
Tolcapone—Hypertension—Doxorubicin—breast cancer	2.25e-05	9.98e-05	CcSEcCtD
Tolcapone—CYP2C9—Metabolism—COX11—breast cancer	2.25e-05	0.000436	CbGpPWpGaD
Tolcapone—COMT—Metabolism—CYP1A1—breast cancer	2.25e-05	0.000435	CbGpPWpGaD
Tolcapone—Tachycardia—Epirubicin—breast cancer	2.25e-05	9.95e-05	CcSEcCtD
Tolcapone—Musculoskeletal discomfort—Methotrexate—breast cancer	2.24e-05	9.92e-05	CcSEcCtD
Tolcapone—Skin disorder—Epirubicin—breast cancer	2.24e-05	9.9e-05	CcSEcCtD
Tolcapone—COMT—Metabolism—ERCC2—breast cancer	2.23e-05	0.000432	CbGpPWpGaD
Tolcapone—Hyperhidrosis—Epirubicin—breast cancer	2.23e-05	9.85e-05	CcSEcCtD
Tolcapone—Arthralgia—Doxorubicin—breast cancer	2.22e-05	9.84e-05	CcSEcCtD
Tolcapone—Myalgia—Doxorubicin—breast cancer	2.22e-05	9.84e-05	CcSEcCtD
Tolcapone—Chest pain—Doxorubicin—breast cancer	2.22e-05	9.84e-05	CcSEcCtD
Tolcapone—Anxiety—Doxorubicin—breast cancer	2.21e-05	9.8e-05	CcSEcCtD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—breast cancer	2.21e-05	0.000428	CbGpPWpGaD
Tolcapone—Paraesthesia—Methotrexate—breast cancer	2.21e-05	9.78e-05	CcSEcCtD
Tolcapone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	2.21e-05	9.77e-05	CcSEcCtD
Tolcapone—Discomfort—Doxorubicin—breast cancer	2.19e-05	9.72e-05	CcSEcCtD
Tolcapone—Anorexia—Epirubicin—breast cancer	2.19e-05	9.72e-05	CcSEcCtD
Tolcapone—Dyspnoea—Methotrexate—breast cancer	2.19e-05	9.71e-05	CcSEcCtD
Tolcapone—Somnolence—Methotrexate—breast cancer	2.19e-05	9.68e-05	CcSEcCtD
Tolcapone—Dizziness—Capecitabine—breast cancer	2.18e-05	9.68e-05	CcSEcCtD
Tolcapone—Dry mouth—Doxorubicin—breast cancer	2.17e-05	9.62e-05	CcSEcCtD
Tolcapone—Vomiting—Docetaxel—breast cancer	2.17e-05	9.61e-05	CcSEcCtD
Tolcapone—Dyspepsia—Methotrexate—breast cancer	2.16e-05	9.59e-05	CcSEcCtD
Tolcapone—Rash—Docetaxel—breast cancer	2.15e-05	9.53e-05	CcSEcCtD
Tolcapone—Hypotension—Epirubicin—breast cancer	2.15e-05	9.52e-05	CcSEcCtD
Tolcapone—Dermatitis—Docetaxel—breast cancer	2.15e-05	9.52e-05	CcSEcCtD
Tolcapone—Confusional state—Doxorubicin—breast cancer	2.15e-05	9.51e-05	CcSEcCtD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—breast cancer	2.15e-05	0.000415	CbGpPWpGaD
Tolcapone—Decreased appetite—Methotrexate—breast cancer	2.14e-05	9.47e-05	CcSEcCtD
Tolcapone—Headache—Docetaxel—breast cancer	2.14e-05	9.47e-05	CcSEcCtD
Tolcapone—Oedema—Doxorubicin—breast cancer	2.13e-05	9.43e-05	CcSEcCtD
Tolcapone—Gastrointestinal disorder—Methotrexate—breast cancer	2.12e-05	9.4e-05	CcSEcCtD
Tolcapone—Fatigue—Methotrexate—breast cancer	2.12e-05	9.39e-05	CcSEcCtD
Tolcapone—Infection—Doxorubicin—breast cancer	2.12e-05	9.37e-05	CcSEcCtD
Tolcapone—Pain—Methotrexate—breast cancer	2.1e-05	9.31e-05	CcSEcCtD
Tolcapone—Vomiting—Capecitabine—breast cancer	2.1e-05	9.3e-05	CcSEcCtD
Tolcapone—Musculoskeletal discomfort—Epirubicin—breast cancer	2.1e-05	9.29e-05	CcSEcCtD
Tolcapone—Shock—Doxorubicin—breast cancer	2.1e-05	9.28e-05	CcSEcCtD
Tolcapone—COMT—Metabolism—MTHFR—breast cancer	2.09e-05	0.000406	CbGpPWpGaD
Tolcapone—Nervous system disorder—Doxorubicin—breast cancer	2.09e-05	9.25e-05	CcSEcCtD
Tolcapone—Thrombocytopenia—Doxorubicin—breast cancer	2.09e-05	9.23e-05	CcSEcCtD
Tolcapone—Rash—Capecitabine—breast cancer	2.08e-05	9.23e-05	CcSEcCtD
Tolcapone—Dermatitis—Capecitabine—breast cancer	2.08e-05	9.22e-05	CcSEcCtD
Tolcapone—Tachycardia—Doxorubicin—breast cancer	2.08e-05	9.2e-05	CcSEcCtD
Tolcapone—Headache—Capecitabine—breast cancer	2.07e-05	9.17e-05	CcSEcCtD
Tolcapone—Skin disorder—Doxorubicin—breast cancer	2.07e-05	9.16e-05	CcSEcCtD
Tolcapone—Paraesthesia—Epirubicin—breast cancer	2.07e-05	9.15e-05	CcSEcCtD
Tolcapone—Hyperhidrosis—Doxorubicin—breast cancer	2.06e-05	9.12e-05	CcSEcCtD
Tolcapone—CYP2C9—Metabolism—SHMT1—breast cancer	2.06e-05	0.000398	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—CDA—breast cancer	2.06e-05	0.000398	CbGpPWpGaD
Tolcapone—Dyspnoea—Epirubicin—breast cancer	2.05e-05	9.09e-05	CcSEcCtD
Tolcapone—Somnolence—Epirubicin—breast cancer	2.05e-05	9.06e-05	CcSEcCtD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—breast cancer	2.03e-05	0.000393	CbGpPWpGaD
Tolcapone—Anorexia—Doxorubicin—breast cancer	2.03e-05	8.99e-05	CcSEcCtD
Tolcapone—Nausea—Docetaxel—breast cancer	2.03e-05	8.98e-05	CcSEcCtD
Tolcapone—Feeling abnormal—Methotrexate—breast cancer	2.03e-05	8.98e-05	CcSEcCtD
Tolcapone—Dyspepsia—Epirubicin—breast cancer	2.03e-05	8.97e-05	CcSEcCtD
Tolcapone—Gastrointestinal pain—Methotrexate—breast cancer	2.01e-05	8.91e-05	CcSEcCtD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—breast cancer	2.01e-05	0.000389	CbGpPWpGaD
Tolcapone—Decreased appetite—Epirubicin—breast cancer	2e-05	8.86e-05	CcSEcCtD
Tolcapone—Hypotension—Doxorubicin—breast cancer	1.99e-05	8.81e-05	CcSEcCtD
Tolcapone—Gastrointestinal disorder—Epirubicin—breast cancer	1.99e-05	8.8e-05	CcSEcCtD
Tolcapone—Fatigue—Epirubicin—breast cancer	1.98e-05	8.79e-05	CcSEcCtD
Tolcapone—CYP2C9—Metabolism—SLC2A5—breast cancer	1.98e-05	0.000383	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—SLCO1B1—breast cancer	1.98e-05	0.000383	CbGpPWpGaD
Tolcapone—Pain—Epirubicin—breast cancer	1.97e-05	8.72e-05	CcSEcCtD
Tolcapone—Constipation—Epirubicin—breast cancer	1.97e-05	8.72e-05	CcSEcCtD
Tolcapone—Nausea—Capecitabine—breast cancer	1.96e-05	8.69e-05	CcSEcCtD
Tolcapone—Urticaria—Methotrexate—breast cancer	1.95e-05	8.65e-05	CcSEcCtD
Tolcapone—Abdominal pain—Methotrexate—breast cancer	1.94e-05	8.61e-05	CcSEcCtD
Tolcapone—Body temperature increased—Methotrexate—breast cancer	1.94e-05	8.61e-05	CcSEcCtD
Tolcapone—Musculoskeletal discomfort—Doxorubicin—breast cancer	1.94e-05	8.59e-05	CcSEcCtD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—NCOA2—breast cancer	1.93e-05	0.000375	CbGpPWpGaD
Tolcapone—COMT—Metabolism—CAV1—breast cancer	1.93e-05	0.000374	CbGpPWpGaD
Tolcapone—Paraesthesia—Doxorubicin—breast cancer	1.91e-05	8.47e-05	CcSEcCtD
Tolcapone—CYP2C9—Metabolism—APRT—breast cancer	1.91e-05	0.00037	CbGpPWpGaD
Tolcapone—Dyspnoea—Doxorubicin—breast cancer	1.9e-05	8.41e-05	CcSEcCtD
Tolcapone—Feeling abnormal—Epirubicin—breast cancer	1.9e-05	8.4e-05	CcSEcCtD
Tolcapone—Somnolence—Doxorubicin—breast cancer	1.89e-05	8.38e-05	CcSEcCtD
Tolcapone—Gastrointestinal pain—Epirubicin—breast cancer	1.88e-05	8.33e-05	CcSEcCtD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—FASN—breast cancer	1.88e-05	0.000363	CbGpPWpGaD
Tolcapone—Dyspepsia—Doxorubicin—breast cancer	1.87e-05	8.3e-05	CcSEcCtD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—breast cancer	1.87e-05	0.000362	CbGpPWpGaD
Tolcapone—Decreased appetite—Doxorubicin—breast cancer	1.85e-05	8.2e-05	CcSEcCtD
Tolcapone—Gastrointestinal disorder—Doxorubicin—breast cancer	1.84e-05	8.14e-05	CcSEcCtD
Tolcapone—Fatigue—Doxorubicin—breast cancer	1.84e-05	8.13e-05	CcSEcCtD
Tolcapone—Urticaria—Epirubicin—breast cancer	1.83e-05	8.1e-05	CcSEcCtD
Tolcapone—Constipation—Doxorubicin—breast cancer	1.82e-05	8.06e-05	CcSEcCtD
Tolcapone—Pain—Doxorubicin—breast cancer	1.82e-05	8.06e-05	CcSEcCtD
Tolcapone—Body temperature increased—Epirubicin—breast cancer	1.82e-05	8.06e-05	CcSEcCtD
Tolcapone—Abdominal pain—Epirubicin—breast cancer	1.82e-05	8.06e-05	CcSEcCtD
Tolcapone—Hypersensitivity—Methotrexate—breast cancer	1.81e-05	8.02e-05	CcSEcCtD
Tolcapone—CYP2C9—Metabolism—ANGPTL4—breast cancer	1.8e-05	0.000348	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—ESRRA—breast cancer	1.8e-05	0.000348	CbGpPWpGaD
Tolcapone—Asthenia—Methotrexate—breast cancer	1.76e-05	7.81e-05	CcSEcCtD
Tolcapone—COMT—Metabolism—PIK3CG—breast cancer	1.76e-05	0.000341	CbGpPWpGaD
Tolcapone—Feeling abnormal—Doxorubicin—breast cancer	1.75e-05	7.77e-05	CcSEcCtD
Tolcapone—Gastrointestinal pain—Doxorubicin—breast cancer	1.74e-05	7.71e-05	CcSEcCtD
Tolcapone—Pruritus—Methotrexate—breast cancer	1.74e-05	7.71e-05	CcSEcCtD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—breast cancer	1.71e-05	0.000331	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—HADHB—breast cancer	1.7e-05	0.00033	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—GPI—breast cancer	1.7e-05	0.00033	CbGpPWpGaD
Tolcapone—Hypersensitivity—Epirubicin—breast cancer	1.7e-05	7.51e-05	CcSEcCtD
Tolcapone—Urticaria—Doxorubicin—breast cancer	1.69e-05	7.49e-05	CcSEcCtD
Tolcapone—Body temperature increased—Doxorubicin—breast cancer	1.68e-05	7.46e-05	CcSEcCtD
Tolcapone—Abdominal pain—Doxorubicin—breast cancer	1.68e-05	7.46e-05	CcSEcCtD
Tolcapone—Diarrhoea—Methotrexate—breast cancer	1.68e-05	7.45e-05	CcSEcCtD
Tolcapone—Asthenia—Epirubicin—breast cancer	1.65e-05	7.31e-05	CcSEcCtD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—NCOA1—breast cancer	1.63e-05	0.000316	CbGpPWpGaD
Tolcapone—Pruritus—Epirubicin—breast cancer	1.63e-05	7.21e-05	CcSEcCtD
Tolcapone—Dizziness—Methotrexate—breast cancer	1.63e-05	7.2e-05	CcSEcCtD
Tolcapone—CYP2C9—Metabolism—ALDH7A1—breast cancer	1.63e-05	0.000315	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—ALDH1A1—breast cancer	1.63e-05	0.000315	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—breast cancer	1.61e-05	0.000311	CbGpPWpGaD
Tolcapone—Diarrhoea—Epirubicin—breast cancer	1.57e-05	6.97e-05	CcSEcCtD
Tolcapone—Hypersensitivity—Doxorubicin—breast cancer	1.57e-05	6.95e-05	CcSEcCtD
Tolcapone—Vomiting—Methotrexate—breast cancer	1.56e-05	6.93e-05	CcSEcCtD
Tolcapone—CYP2C9—Metabolism—PHGDH—breast cancer	1.56e-05	0.000302	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—UMPS—breast cancer	1.56e-05	0.000302	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—ADSL—breast cancer	1.56e-05	0.000302	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—NME1—breast cancer	1.56e-05	0.000302	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—FHL2—breast cancer	1.56e-05	0.000302	CbGpPWpGaD
Tolcapone—Rash—Methotrexate—breast cancer	1.55e-05	6.87e-05	CcSEcCtD
Tolcapone—Dermatitis—Methotrexate—breast cancer	1.55e-05	6.86e-05	CcSEcCtD
Tolcapone—COMT—Metabolism—PIK3CD—breast cancer	1.55e-05	0.0003	CbGpPWpGaD
Tolcapone—Headache—Methotrexate—breast cancer	1.54e-05	6.82e-05	CcSEcCtD
Tolcapone—CYP2C9—Metabolism—HPSE—breast cancer	1.53e-05	0.000296	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—LDHB—breast cancer	1.53e-05	0.000296	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—BRIP1—breast cancer	1.53e-05	0.000296	CbGpPWpGaD
Tolcapone—Asthenia—Doxorubicin—breast cancer	1.53e-05	6.77e-05	CcSEcCtD
Tolcapone—COMT—Metabolism—ALB—breast cancer	1.53e-05	0.000296	CbGpPWpGaD
Tolcapone—Dizziness—Epirubicin—breast cancer	1.52e-05	6.74e-05	CcSEcCtD
Tolcapone—Pruritus—Doxorubicin—breast cancer	1.51e-05	6.67e-05	CcSEcCtD
Tolcapone—Vomiting—Epirubicin—breast cancer	1.46e-05	6.48e-05	CcSEcCtD
Tolcapone—COMT—Metabolism—NOS3—breast cancer	1.46e-05	0.000283	CbGpPWpGaD
Tolcapone—Nausea—Methotrexate—breast cancer	1.46e-05	6.47e-05	CcSEcCtD
Tolcapone—Diarrhoea—Doxorubicin—breast cancer	1.46e-05	6.45e-05	CcSEcCtD
Tolcapone—Rash—Epirubicin—breast cancer	1.45e-05	6.43e-05	CcSEcCtD
Tolcapone—Dermatitis—Epirubicin—breast cancer	1.45e-05	6.42e-05	CcSEcCtD
Tolcapone—CYP2C9—Metabolism—HMMR—breast cancer	1.45e-05	0.000281	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—GSTA3—breast cancer	1.45e-05	0.000281	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—ABCC1—breast cancer	1.45e-05	0.000281	CbGpPWpGaD
Tolcapone—Headache—Epirubicin—breast cancer	1.44e-05	6.39e-05	CcSEcCtD
Tolcapone—Dizziness—Doxorubicin—breast cancer	1.41e-05	6.24e-05	CcSEcCtD
Tolcapone—CYP2C9—Metabolism—PPARGC1B—breast cancer	1.4e-05	0.000272	CbGpPWpGaD
Tolcapone—Nausea—Epirubicin—breast cancer	1.37e-05	6.05e-05	CcSEcCtD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—breast cancer	1.37e-05	0.000265	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—breast cancer	1.37e-05	0.000265	CbGpPWpGaD
Tolcapone—Vomiting—Doxorubicin—breast cancer	1.35e-05	6e-05	CcSEcCtD
Tolcapone—COMT—Metabolism—PIK3CB—breast cancer	1.35e-05	0.000261	CbGpPWpGaD
Tolcapone—Rash—Doxorubicin—breast cancer	1.34e-05	5.95e-05	CcSEcCtD
Tolcapone—Dermatitis—Doxorubicin—breast cancer	1.34e-05	5.94e-05	CcSEcCtD
Tolcapone—COMT—Metabolism—PTGS2—breast cancer	1.34e-05	0.000259	CbGpPWpGaD
Tolcapone—Headache—Doxorubicin—breast cancer	1.33e-05	5.91e-05	CcSEcCtD
Tolcapone—CYP2C9—Metabolism—GSTA4—breast cancer	1.33e-05	0.000257	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—CA9—breast cancer	1.33e-05	0.000257	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—breast cancer	1.31e-05	0.000253	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	1.3e-05	0.000251	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—GPX2—breast cancer	1.29e-05	0.00025	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—GSTA2—breast cancer	1.29e-05	0.00025	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—SULT1A1—breast cancer	1.28e-05	0.000247	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—GPX4—breast cancer	1.28e-05	0.000247	CbGpPWpGaD
Tolcapone—Nausea—Doxorubicin—breast cancer	1.26e-05	5.6e-05	CcSEcCtD
Tolcapone—CYP2C9—Metabolism—GSTA1—breast cancer	1.25e-05	0.000241	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—IDH1—breast cancer	1.25e-05	0.000241	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—NAT2—breast cancer	1.23e-05	0.000239	CbGpPWpGaD
Tolcapone—COMT—Metabolism—PTEN—breast cancer	1.17e-05	0.000226	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—breast cancer	1.11e-05	0.000216	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—MED12—breast cancer	1.08e-05	0.000209	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—DPYD—breast cancer	1.08e-05	0.000209	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—ALDOA—breast cancer	1.06e-05	0.000206	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—NCOA3—breast cancer	1.03e-05	0.0002	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—SLC2A2—breast cancer	1.03e-05	0.000199	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	1.01e-05	0.000196	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—CPT1A—breast cancer	1e-05	0.000195	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—MTR—breast cancer	1e-05	0.000195	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—ABCG2—breast cancer	1e-05	0.000195	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—HPGDS—breast cancer	9.85e-06	0.000191	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—HBA1—breast cancer	9.79e-06	0.00019	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—ACHE—breast cancer	9.55e-06	0.000185	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—GSTT1—breast cancer	9.55e-06	0.000185	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—CYP17A1—breast cancer	9.04e-06	0.000175	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—ENO1—breast cancer	8.95e-06	0.000173	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—PTGS1—breast cancer	8.95e-06	0.000173	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	8.92e-06	0.000173	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—breast cancer	8.8e-06	0.000171	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—CYP2D6—breast cancer	8.78e-06	0.00017	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—NCOA2—breast cancer	8.62e-06	0.000167	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—FASN—breast cancer	8.36e-06	0.000162	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—BCHE—breast cancer	8.32e-06	0.000161	CbGpPWpGaD
Tolcapone—COMT—Metabolism—PIK3CA—breast cancer	8.22e-06	0.000159	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—SLC5A5—breast cancer	8.22e-06	0.000159	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—NQO1—breast cancer	7.94e-06	0.000154	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—SLC2A1—breast cancer	7.94e-06	0.000154	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	7.77e-06	0.000151	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—CYP3A4—breast cancer	7.74e-06	0.00015	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	7.7e-06	0.000149	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—CYP1B1—breast cancer	7.61e-06	0.000147	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—HSP90AA1—breast cancer	7.46e-06	0.000145	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—NCOA1—breast cancer	7.26e-06	0.000141	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—STK11—breast cancer	7.16e-06	0.000139	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—CYP19A1—breast cancer	7.16e-06	0.000139	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—breast cancer	6.72e-06	0.00013	CbGpPWpGaD
Tolcapone—COMT—Metabolism—AKT1—breast cancer	6.72e-06	0.00013	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—COMT—breast cancer	6.65e-06	0.000129	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—GSTP1—breast cancer	6.62e-06	0.000128	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—HMOX1—breast cancer	6.53e-06	0.000126	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—ITPR1—breast cancer	6.52e-06	0.000126	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—ABCB1—breast cancer	6.27e-06	0.000121	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—TYMS—breast cancer	6.16e-06	0.000119	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—PLA2G4A—breast cancer	6.08e-06	0.000118	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—GSTM1—breast cancer	6.08e-06	0.000118	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—NCOR1—breast cancer	6.08e-06	0.000118	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—GPX1—breast cancer	5.83e-06	0.000113	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—CYP1A1—breast cancer	5.77e-06	0.000112	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—ERCC2—breast cancer	5.72e-06	0.000111	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—MTHFR—breast cancer	5.38e-06	0.000104	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—CAV1—breast cancer	4.96e-06	9.61e-05	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	4.74e-06	9.18e-05	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—PIK3CG—breast cancer	4.52e-06	8.75e-05	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—PIK3CD—breast cancer	3.97e-06	7.69e-05	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—ALB—breast cancer	3.92e-06	7.59e-05	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—NOS3—breast cancer	3.75e-06	7.26e-05	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—PIK3CB—breast cancer	3.46e-06	6.71e-05	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—PTGS2—breast cancer	3.43e-06	6.64e-05	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—PTEN—breast cancer	2.99e-06	5.79e-05	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—PIK3CA—breast cancer	2.11e-06	4.09e-05	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—AKT1—breast cancer	1.72e-06	3.34e-05	CbGpPWpGaD
